贝达药业涨2.03%，成交额2.04亿元，主力资金净流入958.68万元

Group 1 - The core viewpoint of the news is that Beida Pharmaceutical has shown a significant increase in stock price and trading activity, indicating positive market sentiment [1][2] - As of August 22, Beida Pharmaceutical's stock price rose by 2.03% to 65.38 CNY per share, with a total market capitalization of 27.508 billion CNY [1] - The company has experienced a year-to-date stock price increase of 21.68%, despite a recent decline of 4.04% over the last five trading days [1] Group 2 - As of June 30, the number of shareholders for Beida Pharmaceutical increased by 9.97% to 32,100, while the average circulating shares per person decreased by 9.08% to 13,064 shares [2] - For the first half of 2025, Beida Pharmaceutical reported a revenue of 1.731 billion CNY, reflecting a year-on-year growth of 15.37% [2] - The company has distributed a total of 669 million CNY in dividends since its A-share listing, with 184 million CNY distributed over the past three years [2]